共 50 条
Identification of candidate biomarkers correlated with the pathogenesis and prognosis of breast cancer via integrated bioinformatics analysis
被引:15
|作者:
Liu, Shuyu
[1
]
Liu, Xinkui
[1
]
Wu, Jiarui
[1
]
Zhou, Wei
[1
]
Ni, Mengwei
[1
]
Meng, Ziqi
[1
]
Jia, Shanshan
[1
]
Zhang, Jingyuan
[1
]
Guo, Siyu
[1
]
Lu, Shan
[1
]
Li, Yingfei
[2
]
机构:
[1] Beijing Univ Chinese Med, Sch Chinese Mat Med, Dept Clin Chinese Pharm, 11 North Three Ring East Rd, Beijing, Peoples R China
[2] China Acad Chinese Med Sci, Inst Chinese Mat Med, Ctr Drug Metab & Pharmacokinet Res Res Herbal Med, Beijing, Peoples R China
来源:
关键词:
bioinformatics;
biomarker;
breast cancer;
differentially expressed genes;
Gene Expression Omnibus;
survival;
CYCLIN B2 EXPRESSION;
GENE-EXPRESSION;
CHROMOSOME ALIGNMENT;
TOPOISOMERASE-II;
FAMILY-MEMBER;
BUB1;
LUNG;
B1;
PROTEIN;
CELLS;
D O I:
10.1097/MD.0000000000023153
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Background: This study was carried out to identify potential key genes associated with the pathogenesis and prognosis of breast cancer (BC). Methods: Seven GEO datasets (GSE24124, GSE32641, GSE36295, GSE42568, GSE53752, GSE70947, GSE109169) were downloaded from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) between BC and normal breast tissue samples were screened by an integrated analysis of multiple gene expression profile datasets. Hub genes related to the pathogenesis and prognosis of BC were verified by employing protein-protein interaction (PPI) network. Results: Ten hub genes with high degree were identified, including CDK1, CDC20, CCNA2, CCNB1, CCNB2, BUB1, BUB1B, CDCA8, KIF11, and TOP2A. Lastly, the Kaplan-Meier plotter (KM plotter) online database demonstrated that higher expression levels of these genes were related to lower overall survival. Experimental validation showed that all 10 hub genes had the same expression trend as predicted. Conclusion: The findings of this research would provide some directive significance for further investigating the diagnostic and prognostic biomarkers to facilitate the molecular targeting therapy of BC, which could be used as a new biomarker for diagnosis and to guide the combination medicine of BC.
引用
收藏
页数:13
相关论文